ROKA 3.00 Roka Bioscience Inc $ROKA Hit a 52 week low of 2.97 Currently at 3.00 -5.34 -64.03% With a day low of 2.97 and a total volume of 2,459,200.
ROKA Roka Bioscience Inc Recent Headline News
Roka Bioscience Reports Third Quarter 2014 Financial Results
PR Newswire - Thu Nov 06, 3:01PM CST
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three months ended September 30, 2014.
ROKA: 3.00 (-5.34)
Roka Bioscience to Report Third Quarter 2014 Financial Results On November 6, 2014
PR Newswire - Thu Oct 30, 10:00AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA) , a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the third quarter of 2014 on November 6, 2014 after the close of the financial markets.
ROKA: 3.00 (-5.34)
Roka Bioscience Reports Second Quarter 2014 Financial Results
PR Newswire - Mon Aug 11, 6:00AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three and six months ended June 30, 2014.
ROKA: 3.00 (-5.34)
Roka Bioscience to Report Second Quarter 2014 Financial Results On August 11, 2014
PR Newswire - Mon Aug 04, 7:30AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the second quarter of 2014 on August 11, 2014 before the open of the financial markets.
ROKA: 3.00 (-5.34)
Roka Bioscience, Inc. (NASDAQ: ROKA) to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Tue Jul 22, 9:00AM CDT
What:
ROKA: 3.00 (-5.34), NDAQ: 43.88 (-0.02)
Zacks Investment Ideas feature highlights: Tube Mogul, YuMe, CareDX, Roka Bioscience, Goldman Sachs and Terraform Power
PR Newswire - Fri Jul 18, 8:30AM CDT
Today, Zacks Investment Ideas feature highlights Features: Tube Mogul (Nasdaq:TUBE-Free Report), YuMe (NYSE:YUME-Free Report), CareDX (Nasdaq:CDNA-Free Report), Roka Bioscience (Nasdaq:ROKA-Free Report), Goldman Sachs (NYSE:GS-Free Report) and Terraform Power (Nasdaq:TERP-Free Report).
ROKA: 3.00 (-5.34)
IPO Stock Watch: Two Biotechs IPOs Price Below Range
at Investor's Business Daily - Thu Jul 17, 12:53PM CDT
Two of six biotech IPOs planned for this week launched Thursday, both pricing below their projected ranges. Roka Bioscience (ROKA) raised $60 million by offering 5 million shares at 12, though it had expected to price at 14 to 16. Roka develops food...
ROKA: 3.00 (-5.34), SAGE: 38.72 (-0.28), CDNA: 6.10 (-0.03), DOW: 49.50 (-0.31), PFNX: 8.34 (+0.15)
Roka Bioscience Announces Pricing of Initial Public Offering
PR Newswire - Thu Jul 17, 7:30AM CDT
Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $12.00 per share, before underwriting discounts. All of the common stock is being offered by Roka Bioscience. In addition, Roka Bioscience has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price. The shares are expected to begin trading on the NASDAQ Global Market on July 17, 2014 under the ticker symbol "ROKA". The offering is expected to close on July 22, 2014, subject to customary closing conditions.
ROKA: 3.00 (-5.34)
IPO Calendar: 11 IPOs This Week Include 6 Biotechs
at Investor's Business Daily - Mon Jul 14, 1:17PM CDT
Eleven companies plan to make their IPO debuts this week, following the traditionally slow first two weeks of July. The largest initial public offering planned is TerraForm Power (TERP), an owner and operator of solar energy power plants. It's a...
ROKA: 3.00 (-5.34), SAGE: 38.72 (-0.28), TERP: 27.76 (-0.15), GLOB: 14.12 (+0.70), MTBC: 3.35 (-0.10), SUNE: 18.06 (-0.31), TUBE: 16.03 (+0.82), ABY: 32.40 (-0.08), TRUP: 6.54 (-0.21), NYLD: 48.48 (-0.70), PFNX: 8.34 (+0.15), DOW: 49.50 (-0.31)
IPO Stock Watch: Five Biotechs On Upcoming IPO Docket
at Investor's Business Daily - Fri Jul 11, 4:21PM CDT
The market for health care IPOs shows no sign of slowing. Five of nine initial public offerings slated to debut the week of July 14 are in the biotech sector. The largest of these is Roka Bioscience (ROKA), which develops food safety testing...
ROKA: 3.00 (-5.34), DOW: 49.50 (-0.31), PFNX: 8.34 (+0.15)
ROKA Roka Bioscience Inc Recent Headline News
Roka Bioscience Reports Third Quarter 2014 Financial Results
PR Newswire - Thu Nov 06, 3:01PM CST
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three months ended September 30, 2014.
ROKA: 3.00 (-5.34)
Roka Bioscience to Report Third Quarter 2014 Financial Results On November 6, 2014
PR Newswire - Thu Oct 30, 10:00AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA) , a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the third quarter of 2014 on November 6, 2014 after the close of the financial markets.
ROKA: 3.00 (-5.34)
Roka Bioscience Reports Second Quarter 2014 Financial Results
PR Newswire - Mon Aug 11, 6:00AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three and six months ended June 30, 2014.
ROKA: 3.00 (-5.34)
Roka Bioscience to Report Second Quarter 2014 Financial Results On August 11, 2014
PR Newswire - Mon Aug 04, 7:30AM CDT
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the second quarter of 2014 on August 11, 2014 before the open of the financial markets.
ROKA: 3.00 (-5.34)
Roka Bioscience, Inc. (NASDAQ: ROKA) to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Tue Jul 22, 9:00AM CDT
What:
ROKA: 3.00 (-5.34), NDAQ: 43.88 (-0.02)
Zacks Investment Ideas feature highlights: Tube Mogul, YuMe, CareDX, Roka Bioscience, Goldman Sachs and Terraform Power
PR Newswire - Fri Jul 18, 8:30AM CDT
Today, Zacks Investment Ideas feature highlights Features: Tube Mogul (Nasdaq:TUBE-Free Report), YuMe (NYSE:YUME-Free Report), CareDX (Nasdaq:CDNA-Free Report), Roka Bioscience (Nasdaq:ROKA-Free Report), Goldman Sachs (NYSE:GS-Free Report) and Terraform Power (Nasdaq:TERP-Free Report).
ROKA: 3.00 (-5.34)
IPO Stock Watch: Two Biotechs IPOs Price Below Range
at Investor's Business Daily - Thu Jul 17, 12:53PM CDT
Two of six biotech IPOs planned for this week launched Thursday, both pricing below their projected ranges. Roka Bioscience (ROKA) raised $60 million by offering 5 million shares at 12, though it had expected to price at 14 to 16. Roka develops food...
ROKA: 3.00 (-5.34), SAGE: 38.72 (-0.28), CDNA: 6.10 (-0.03), DOW: 49.50 (-0.31), PFNX: 8.34 (+0.15)
Roka Bioscience Announces Pricing of Initial Public Offering
PR Newswire - Thu Jul 17, 7:30AM CDT
Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $12.00 per share, before underwriting discounts. All of the common stock is being offered by Roka Bioscience. In addition, Roka Bioscience has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price. The shares are expected to begin trading on the NASDAQ Global Market on July 17, 2014 under the ticker symbol "ROKA". The offering is expected to close on July 22, 2014, subject to customary closing conditions.
ROKA: 3.00 (-5.34)
IPO Calendar: 11 IPOs This Week Include 6 Biotechs
at Investor's Business Daily - Mon Jul 14, 1:17PM CDT
Eleven companies plan to make their IPO debuts this week, following the traditionally slow first two weeks of July. The largest initial public offering planned is TerraForm Power (TERP), an owner and operator of solar energy power plants. It's a...
ROKA: 3.00 (-5.34), SAGE: 38.72 (-0.28), TERP: 27.76 (-0.15), GLOB: 14.12 (+0.70), MTBC: 3.35 (-0.10), SUNE: 18.06 (-0.31), TUBE: 16.03 (+0.82), ABY: 32.40 (-0.08), TRUP: 6.54 (-0.21), NYLD: 48.48 (-0.70), PFNX: 8.34 (+0.15), DOW: 49.50 (-0.31)
IPO Stock Watch: Five Biotechs On Upcoming IPO Docket
at Investor's Business Daily - Fri Jul 11, 4:21PM CDT
The market for health care IPOs shows no sign of slowing. Five of nine initial public offerings slated to debut the week of July 14 are in the biotech sector. The largest of these is Roka Bioscience (ROKA), which develops food safety testing...
ROKA: 3.00 (-5.34), DOW: 49.50 (-0.31), PFNX: 8.34 (+0.15)
